| NCT06810245 | Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back Pain | RECRUITING | PHASE1 | 2025-02-04 | 2026-02-15 | 2025-12-15 |
| NCT06683612 | PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF | COMPLETED | PHASE1 | 2024-12-09 | 2025-06-12 | 2025-06-04 |
| NCT06083753 | Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects with Relapsing-Remitting Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-11-06 | 2025-09 | 2025-08 |
| NCT05983939 | Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers | COMPLETED | PHASE1 | 2023-06-26 | 2024-02-01 | 2024-02-01 |
| NCT04941781 | PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers | COMPLETED | PHASE1 | 2021-09-01 | 2021-11-10 | 2021-11-10 |
| NCT04725175 | Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers | COMPLETED | PHASE1 | 2021-02-26 | 2021-09-01 | 2021-09-01 |
| NCT04462198 | Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss | COMPLETED | PHASE1, PHASE2 | 2020-10-15 | 2021-06-17 | 2021-06-17 |